We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.225 | 5.81% | 4.10 | 29,115,559 | 16:25:52 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 4.05 | 4.15 | 4.275 | 3.825 | 3.875 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -4.32 | 21.05M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:29:56 | O | 5,000 | 4.0666 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/7/2024 | 19:36 | ALNC |  EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises |
| 15/7/2024 | 07:00 | UK RNS | Genedrive PLC Breakthrough Device Designation from the U.S. FDA |
| 27/6/2024 | 19:29 | ALNC | EARNINGS AND TRADING: Fenikso in profit; Tate & Lyle completes sale |
| 27/6/2024 | 09:28 | UK RNS | Genedrive PLC Short extension to NICE publication date |
| 25/6/2024 | 07:00 | UK RNS | Genedrive PLC Holding(s) in Company |
| 24/6/2024 | 11:13 | UK RNS | Genedrive PLC Holding(s) in Company |
| 24/6/2024 | 11:12 | UK RNS | Genedrive PLC Holding(s) in Company |
| 24/6/2024 | 11:11 | UK RNS | Genedrive PLC Holding(s) in Company |
| 17/6/2024 | 16:41 | UK RNS | Genedrive PLC Holding(s) in Company |
| 13/6/2024 | 15:22 | UK RNS | Genedrive PLC Holding(s) in Company |
Genedrive (GDR) Share Charts1 Year Genedrive Chart |
|
1 Month Genedrive Chart |
Intraday Genedrive Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 19:29 | Genedrive, A Game Changer for Point of Care Testing Market? | 6,524 |
| 26/7/2024 | 17:38 | Shares are poised to rebound very strongly | 1,116 |
| 26/7/2024 | 17:31 | GENEDRIVE MODERATED | 583 |
| 25/7/2024 | 20:39 | GDR is pumped by scammer Zico | 73 |
| 22/7/2024 | 15:01 | TO DATE THEIR KITS HAVE REVENUES OF ONLY Ј100K.GET OUT!! | 32 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:29:57 | 4.07 | 5,000 | 203.33 | O |
| 2024-07-26 15:29:54 | 4.14 | 4,227 | 175.00 | O |
| 2024-07-26 15:29:29 | 4.14 | 8,840 | 365.98 | O |
| 2024-07-26 15:29:06 | 4.09 | 122,455 | 5,005.96 | O |
| 2024-07-26 15:28:50 | 4.09 | 18,459 | 754.60 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Genedrive Daily Update Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 3.88p.Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £22,268,801. Genedrive has a price to earnings ratio (PE ratio) of -4.32. This morning GDR shares opened at 3.88p |
Posted at 26/7/2024 08:43 by batiatus Or the share price will fall sharply.Buy on rumour selling on news. No one actually believes in GDR. They are only here for the spike in share price |
Posted at 25/7/2024 12:46 by batiatus Countbasie1, yeah, your fantasy of GDR doing a 100+ bagger. Unfortunately, your fantasy alone would not lift the share price one bit. |
Posted at 25/7/2024 10:20 by ghost_walker Batiatus25 Jul '24 - 09:40 - 408 of 4150 0 1 Rampers are panicking because no one is foolish enough to take the shares off of them. Buy on rumour and sell on news. If NICE not approved, or it comes with condition, the share price will crash If there is no funding strategy in place, then the share price will also crash. So many hurdles for GDR to get through. Cheek could possibly take the company private too |
Posted at 25/7/2024 09:40 by batiatus Rampers are panicking because no one is foolish enough to take the shares off of them.Buy on rumour and sell on news. If NICE not approved, or it comes with condition, the share price will crash If there is no funding strategy in place, then the share price will also crash. So many hurdles for GDR to get through. Cheek could possibly take the company private too |
Posted at 24/7/2024 21:40 by bones698 Genghis the difference is Gdr have just raised funds so won't be able to take it private without paying the going rate now as they can't use the excuse they can't raise money. The difference with dest is they didn't want to do a madsivelybdillutive raise eandnt0jinknits better to duelist to try and raise money. Wethwr they are right or not remains to be seenfornkenthisnusjaHere that isn't happening yet anyway, and soon provided they start to deliver with the NHS the share price will. Be much higher and provide better options in the future. Nice to see the scarmongers trying desperately to talk it down. NICE news will come and with it the realisation they are out of the game when the share price continues to rise. |
Posted at 24/7/2024 17:05 by countbasie1 SocionomicsIf it bottomed yesterday at the intraday low then the GDR share price could start the 3rd up wave of the Elliot Wave Cycle. Possible target share price is 1.6 x the height of the 1st wave + yesterday's intraday high.. That gives a target price of with an intraday high of around 8p. Alternatively we could get a flag, or pennant, forming until the NICE approval is announced @ the end of July giving an intraday high of around 6.5p+. Which will happen? |
Posted at 24/7/2024 09:15 by batiatus bone698, refer to my previous post. All the answers are in there. Copied below:There are just too many unknowns and things that could go wrong. I've already mentioned one of the red flags being the low income stream. GDR needs the kit to work to keep the company afloat and stop future placing. No more room for mess ups. But we don't know for sure until it happens. NICE might not be given or it could come with conditions. Assuming that NICE is given，there needs to be a strategy to mass produce the kits. By that I mean a financially healthy and error free production line. Another phrase where many things can go wrong. Who is funding the up scaling of production remains unanswered. NHS grant or another placing or third party loan? Investors would also like to see a clear strategy for a profitable business. How will they bring in sales contracts, how much production and how long until the company become break even and financially self-efficient remains unknown. Everything is up in the air but you are selective in what you want to hear anyway. Everyone here wants a quick profit. They will not want to wait around for GDR to overcome all that. Hence I think it's a risky play. Look at MATD today. Production work commenced today with estimated time of completion in mid-august. Nothing wrong with that but the share price drops! Unless you can tell me on the 31st July GDR will rake it millions then tough luck. Because there is still a long road map until we see a healthy balance sheet First and foremost，they need to get NICE FULL recommendation (a certified product) or it's game over because if not they won't have a product to sell. Unless if you admit that you are only in for the spike (like most), then none of the above would concern you. |
Posted at 23/7/2024 20:36 by batiatus Countbasie1, there are just too many unknowns and things that could go wrong.I've already mentioned one of the red flags being the low income stream. GDR needs the kit to work to keep the company afloat and stop future placing. No more room for mess ups. But we don't know for sure until it happens. NICE might not be given or it could come with conditions. Assuming that NICE is given，there needs to be a strategy to mass produce the kits. By that I mean a financially healthy and error free production line. Another phrase where many things can go wrong. Who is funding the up scaling of production remains unanswered. NHS grant or another placing or third party loan? Investors would also like to see a clear strategy for a profitable business. How will they bring in sales contracts, how much production and how long until the company become break even and financially self-efficient remains unknown. Everything is up in the air but you are selective in what you want to hear anyway. Everyone here wants a quick profit. They will not want to wait around for GDR to overcome all that. Hence I think it's a risky play. Look at MATD today. Production work commenced today with estimated time of completion in mid-august. Nothing wrong with that but the share price drops! Unless you can tell me on the 31st July GDR will rake it millions then tough luck. Because there is still a long road map until we see a healthy balance sheet First and foremost，they need to get NICE FULL recommendation (a certified product) or it's game over because if not they won't have a product to sell. Unless if you admit that you are only in for the spike (like most), then none of the above would concern you. |
Posted at 21/7/2024 11:24 by batiatus Z1co' quote:"he panicked and sold on Friday most likely at the lows around 1.75p." 1.75p????? Don't recall the share price being that low. Perhaps if NICE isn't given，then the share price will drift back below the recent placing price. |
Posted at 19/7/2024 22:22 by soulburner Z1co,Why did you ban me if you're not scared? Since you asked for it, I will reply you with my renewed thoughts. It seems all eyes are on NICE update, including myself, IF we get given the Full Recommendation. That's a big IF. What if they don't? The NHS guidelines are very strict. That is why they require on-site testing to gather live data, but that's not all. Data isn't everything. We all know the NHS budget is tight. Shortages of ambulance services, not even qualified nurses and doctors get a fair pay，you really think they would fund a plastic box as some have stated? In the real world, just because you have a functioning product does not mean you are guaranteed to bring it onto production. People are putting all bets on the NICE update. We are all here to make money, the same goes with the company. The question to ask is where will they find the funds to mass produce these kits? Even if they get pass the above hurdles, it's onto commercialization. How long will it be until GDR make any profit? I think a lot of people will sell out prior July 31st, and after regardless of NICE or not, because for this to re-rate sales contracts are needed. In short, there's no short-cut, but if GDR manages to pass all the mentioned hurdles they might be onto something. The carrot (I mean NICE) served it's function for people like you to buy in at a high price. The big boys have flipped shares and are back on the sidelines. The share price looks likely to drift next week. Pump and dump at the highest order, but thank Z1co. Without traders like you, it would never work. Someone must hold the baby. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
